PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages

Rho‐associated kinases (ROCKs) are critical molecules involved in the physiological functions of macrophages, such as chemotaxis and phagocytosis. We demonstrate that macrophage adherence promotes rapid changes in physiological functions that depend on translational upregulation of preformed ROCK‐1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The EMBO journal 2007-01, Vol.26 (2), p.505-515
Hauptverfasser: Fox, Richard, Nhan, Thomas Q, Law, G Lynn, Morris, David R, Liles, W Conrad, Schwartz, Stephen M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rho‐associated kinases (ROCKs) are critical molecules involved in the physiological functions of macrophages, such as chemotaxis and phagocytosis. We demonstrate that macrophage adherence promotes rapid changes in physiological functions that depend on translational upregulation of preformed ROCK‐1 mRNA, but not ROCK‐2 mRNA. Before adherence, both ROCK mRNAs were present in the cytoplasm of macrophages, whereas ROCK proteins were undetectable. Macrophage adherence promoted signaling through P‐selectin glycoprotein ligand‐1 (PSGL‐1)/Akt/mTOR that resulted in synthesis of ROCK‐1, but not ROCK‐2. Following synthesis, ROCK‐1 was catalytically active. In addition, there was a rapamycin/sirolimus‐sensitive enhanced loading of ribosomes on preformed ROCK‐1 mRNAs. Inhibition of mTOR by rapamycin abolished ROCK‐1 synthesis in macrophages resulting in an inhibition of chemotaxis and phagocytosis. Macrophages from PSGL‐1‐deficient mice recapitulated pharmacological inhibitor studies. These results indicate that receptor‐mediated regulation at the level of translation is a component of a rapid set of mechanisms required to direct the macrophage phenotype upon adherence and suggest a mechanism for the immunosuppressive and anti‐inflammatory effects of rapamycin/sirolimus.
ISSN:0261-4189
1460-2075
DOI:10.1038/sj.emboj.7601522